Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Provalis PLC (NasdaqNM:PVLS)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Msgs
Location
Newtech Square, Deeside
Flintshire CH5 2NT, UK
Email: enquiries@provalis.plc.uk
Employees (last reported count): 98
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 47%
·Institutional: 0% (0% of float)
(4 institutions)
·Net Inst. Selling: 13.0K shares
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Provalis PLC is an integrated healthcare company with three separate divisions focused on the supply and sale of prescription medicines, the development and global sale of medical diagnostics and the development of new therapeutic products. The Healthcare division supplies, sells and markets branded third party prescription medicines in the United Kingdom to general practitioners and hospitals. Its product range includes products for use in the medical areas of gastroenterology, osteoporosis, migraine and dermatology. The Medical Diagnostics division develops and sells medical diagnostic products to world markets through distributors. The division has launched the diagnostic products Glycosal and Osteosal, in the areas of diabetes and osteoporosis respectively, and also has a worldwide franchise in diagnostic products for infectious diseases. The Therapeutics Research & Development division develops new therapeutic products, focusing on vaccine candidates for infectious diseases.
More from Market Guide: Expanded Business Description

Financial Summary
Provalis Plc is an integrated healthcare company engaged in the supply and sale of prescription drugs and the development and sale of medical diagnostics and new therapeutic products. For the six months ended 12/00, revenues rose 6% to L3.6 million. Net loss fell 56% to L2.1 million. Revenues reflect increased sales from the Medical Diagnostics segment due to the introduction of Glycosal. Lower loss reflects improved operating efficiencies and R&D tax credits.
More from Market Guide: Significant Developments

Officers

Position
Phillip GouldCEO
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:PVLSAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$0.75 
Recent Price$0.85 
52-Week High
on 5-Sep-2000
$2.75 
Beta1.39 
Daily Volume (3-month avg)1,045 
Daily Volume (10-day avg)2,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-68.7%
52-Week Change
relative to S&P500
-58.1%
Share-Related Items
Market Capitalization$27.0M
Shares Outstanding31.7M
Float16.8M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.45 
Earnings (ttm)-$0.17 
Earnings (mrq)-$0.07 
Sales (ttm)$0.25 
Cash (mrq)$0.43 
Valuation Ratios
Price/Book (mrq)1.90 
Price/EarningsN/A 
Price/Sales (ttm)3.35 
Income Statements
Sales (ttm)$10.2M
EBITDA (ttm)-$6.69M
Income available to common (ttm)-$6.98M
Profitability
Profit Margin (ttm)-68.6%
Operating Margin (ttm)-75.7%
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter31-Dec-2000
Management Effectiveness
Return on Assets (ttm)-21.92%
Return on Equity (ttm)-60.00%
Financial Strength
Current Ratio (mrq)4.90 
Debt/Equity (mrq)0.02 
Total Cash (mrq)$17.9M
Short Interest
As of 8-Aug-2001
Shares Short2,000 
Percent of Float0.0%
Shares Short
(Prior Month)
2,000 
Short Ratio2.00 
Daily Volume1,000 
ADR Information
Shares/ADR5
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-Dec-2000);   dollar amounts based on an exchange rate of 1.45 Dollars/British Pounds

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.